$13.12
1.47%
Nasdaq, Jan 02, 10:00 pm CET
ISIN
JE00BYSS4X48
Symbol
NVCR

Novocure Ltd. Stock price

$13.12
+2.20 20.15% 1M
-4.76 26.62% 6M
+0.19 1.47% YTD
-16.87 56.25% 1Y
-60.23 82.11% 3Y
-148.20 91.87% 5Y
-9.43 41.82% 10Y
-5.16 28.23% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+0.19 1.47%

New AI Insights on Novocure Ltd. Insights AI Insights on Novocure Ltd.

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$1.5b
Enterprise Value
$1.2b
Net debt
positive
Cash
$1.0b
Shares outstanding
112.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.3 | 2.2
EV/Sales
1.9 | 1.8
EV/FCF
negative
P/B
4.3
Financial Health
Equity Ratio
29.0%
Return on Equity
-46.8%
ROCE
-30.0%
ROIC
-184.6%
Debt/Equity
2.2
Financials (TTM | estimate)
Revenue
$642.3m | $664.2m
EBITDA
$-162.1m | $-48.3m
EBIT
$-175.6m | $-159.6m
Net Income
$-177.7m | $-158.1m
Free Cash Flow
$-65.2m
Growth (TTM | estimate)
Revenue
11.2% | 9.8%
EBITDA
-11.0% | 69.3%
EBIT
-11.9% | 5.3%
Net Income
-18.6% | 6.3%
Free Cash Flow
16.7%
Margin (TTM | estimate)
Gross
75.6%
EBITDA
-25.2% | -7.3%
EBIT
-27.3%
Net
-27.7% | -23.8%
Free Cash Flow
-10.2%
More
EPS
$-1.6
FCF per Share
$-0.6
Short interest
9.8%
Employees
1k
Rev per Employee
$410.0k
Show more

Is Novocure Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Novocure Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Novocure Ltd. forecast:

10x Buy
77%
3x Hold
23%

Analyst Opinions

13 Analysts have issued a Novocure Ltd. forecast:

Buy
77%
Hold
23%

Financial data from Novocure Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
642 642
11% 11%
100%
- Direct Costs 157 157
15% 15%
24%
485 485
10% 10%
76%
- Selling and Administrative Expenses 444 444
15% 15%
69%
- Research and Development Expense 215 215
1% 1%
33%
-162 -162
11% 11%
-25%
- Depreciation and Amortization 14 14
25% 25%
2%
EBIT (Operating Income) EBIT -176 -176
12% 12%
-27%
Net Profit -178 -178
19% 19%
-28%

In millions USD.

Don't miss a Thing! We will send you all news about Novocure Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Novocure Ltd. Stock News

Neutral
Seeking Alpha
one day ago
Despite an expected 7% revenue growth for FY2025, NVCR stock price was cut in half in 2025 following the disappointing adoption of Optune Lua in the US and Germany. Yet, the company pipeline has multiple shots on goal which could materially improve its revenue growth trajectory and profitability as early as 2027. Most key approvals and data readouts are expected in 2026, representing potential ...
Neutral
Business Wire
13 days ago
BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that management will participate in the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco on January 12-15, 2026. Frank Leonard, Chief Executive Officer, will present on behalf of the company and address questions on Wednesday, January 14, at 9:45 a.m. PST. Mr. Leonard will be joined by William...
Neutral
Business Wire
about one month ago
BAAR, Switzerland--(BUSINESS WIRE)---- $NVCR--Novocure (NASDAQ: NVCR) today announced the appointment of Frank Leonard as Chief Executive Officer (CEO), effective immediately. Mr. Leonard previously served as President of Novocure and succeeds Ashley Cordova who has resigned from the company. “During his more than 15-year career at Novocure, Frank has led many of our global business operations ...
More Novocure Ltd. News

Company Profile

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

Head office Jersey
CEO Ms. Cordova
Employees 1,488
Founded 2000
Website www.novocure.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today